CNS Drugs provides researchers and healthcare professionals involved in the care of individuals with neurological and psychiatric disorders with essential information on the most important aspects of drug therapy. Via a program of review articles, the journal addresses the major issues relating to the drug therapy of these disorders. These include the pharmacology, efficacy and adverse effects of the major classes of drugs used by neurologists and psychiatrists; information on newly developed drugs and drug classes; the therapeutic implications of the latest research into the aetiology of neurological and psychiatric disorders; and the practical management of specific disorders. CNS Drugs also offers a vehicle for the publication of important clinical research papers to assist in the dissemination of information on which clinicians can base their prescribing.
27 Volumes 259 Issues 1,735 Articles available from 1994 - 2013Browse Volumes & Issues
Acknowledgement to Referees
Adis Drug Evaluation
Karly P. Garnock-Jones (December 2013)
To view the rest of this content please follow the download PDF link above.